Enovis (ENOV) Notes Payables (2015 - 2016)
Enovis (ENOV) posted quarterly Notes Payables of $151.0 million for Q4 2016, down 22.57% year-over-year from $195.0 million in Q1 2016, and down 22.57% quarter-over-quarter from $195.0 million in Q4 2015.
Enovis (ENOV) Notes Payables (2015 - 2016) Analysis & Trends
Enovis (ENOV) has reported Notes Payables for 2 consecutive years, with $151.0 million the latest figure, recorded in Q4 2016.
- In Q4 2016, Notes Payables fell 22.57% year-over-year to $151.0 million; the TTM figure through Dec 2016 stood at $151.0 million (down 22.57% YoY), while the FY2016 annual figure was $151.0 million, down 22.57% from the prior year.
- Notes Payables fell to $151.0 million in Q4 2016 per ENOV's latest filing, from $195.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $195.0 million in Q4 2015 and bottomed at $151.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Enovis | 1.53 Bn | 1.52 Bn | 359.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 151.02 Mn |
| Dec 31, 2015 | 195.04 Mn |